Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study (Leukemia, (2021), 35, 6, (1671-1682), 10.1038/s41375-020-01042-y)

Yong Yang; Ying Wang; Xin Liu; Xia He; Li Ling Zhang; Gang Wu; Bao Lin Qu; Li Ting Qian; Xiao Rong Hou; Fu Quan Zhang; Xue Ying Qiao; Hua Wang; Gao Feng Li; Yuan Zhu; Jian Zhong Cao; Jun Xin Wu; Tao Wu; Su Yu Zhu; Mei Shi; Li Ming Xu; Hang Su; Yu Qin Song; Jun Zhu; Yu Jing Zhang; Hui Qiang Huang; Chen Hu; Shu Nan Qi; Ye Xiong Li

doi:10.1038/s41375-021-01371-6

Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study (Leukemia, (2021), 35, 6, (1671-1682), 10.1038/s41375-020-01042-y)

Yong Yang, Ying Wang, Xin Liu, Xia He, Li Ling Zhang, Gang Wu, Bao Lin Qu, Li Ting Qian, Xiao Rong Hou, Fu Quan Zhang, Xue Ying Qiao, Hua Wang, Gao Feng Li, Yuan Zhu, Jian Zhong Cao, Jun Xin Wu, Tao Wu, Su Yu Zhu, Mei Shi, Li Ming XuHang Su, Yu Qin Song, Jun Zhu, Yu Jing Zhang, Hui Qiang Huang, Chen Hu, Shu Nan Qi, Ye Xiong Li

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Table 3 of the original article was not correct. The corrected version can be found below.

Original language	English (US)
Pages (from-to)	2736-2737
Number of pages	2
Journal	Leukemia
Volume	35
Issue number	9
DOIs	https://doi.org/10.1038/s41375-021-01371-6
State	Published - Sep 2021

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-021-01371-6

Fingerprint

Dive into the research topics of 'Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study (Leukemia, (2021), 35, 6, (1671-1682), 10.1038/s41375-020-01042-y)'. Together they form a unique fingerprint.

Cite this

Yang, Y., Wang, Y., Liu, X., He, X., Zhang, L. L., Wu, G., Qu, B. L., Qian, L. T., Hou, X. R., Zhang, F. Q., Qiao, X. Y., Wang, H., Li, G. F., Zhu, Y., Cao, J. Z., Wu, J. X., Wu, T., Zhu, S. Y., Shi, M., ... Li, Y. X. (2021). Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study (Leukemia, (2021), 35, 6, (1671-1682), 10.1038/s41375-020-01042-y). Leukemia, 35(9), 2736-2737. https://doi.org/10.1038/s41375-021-01371-6

Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study (Leukemia, (2021), 35, 6, (1671-1682), 10.1038/s41375-020-01042-y). / Yang, Yong; Wang, Ying; Liu, Xin et al.
In: Leukemia, Vol. 35, No. 9, 09.2021, p. 2736-2737.

Research output: Contribution to journal › Comment/debate › peer-review

Yang, Y, Wang, Y, Liu, X, He, X, Zhang, LL, Wu, G, Qu, BL, Qian, LT, Hou, XR, Zhang, FQ, Qiao, XY, Wang, H, Li, GF, Zhu, Y, Cao, JZ, Wu, JX, Wu, T, Zhu, SY, Shi, M, Xu, LM, Su, H, Song, YQ, Zhu, J, Zhang, YJ, Huang, HQ, Hu, C, Qi, SN & Li, YX 2021, 'Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study (Leukemia, (2021), 35, 6, (1671-1682), 10.1038/s41375-020-01042-y)', Leukemia, vol. 35, no. 9, pp. 2736-2737. https://doi.org/10.1038/s41375-021-01371-6

@article{b7dd4642b0904fd097f6194630d8af39,

title = "Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study (Leukemia, (2021), 35, 6, (1671-1682), 10.1038/s41375-020-01042-y)",

abstract = "Table 3 of the original article was not correct. The corrected version can be found below.",

author = "Yong Yang and Ying Wang and Xin Liu and Xia He and Zhang, {Li Ling} and Gang Wu and Qu, {Bao Lin} and Qian, {Li Ting} and Hou, {Xiao Rong} and Zhang, {Fu Quan} and Qiao, {Xue Ying} and Hua Wang and Li, {Gao Feng} and Yuan Zhu and Cao, {Jian Zhong} and Wu, {Jun Xin} and Tao Wu and Zhu, {Su Yu} and Mei Shi and Xu, {Li Ming} and Hang Su and Song, {Yu Qin} and Jun Zhu and Zhang, {Yu Jing} and Huang, {Hui Qiang} and Chen Hu and Qi, {Shu Nan} and Li, {Ye Xiong}",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2021",

month = sep,

doi = "10.1038/s41375-021-01371-6",

language = "English (US)",

volume = "35",

pages = "2736--2737",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Correction to

T2 - Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study (Leukemia, (2021), 35, 6, (1671-1682), 10.1038/s41375-020-01042-y)

AU - Yang, Yong

AU - Wang, Ying

AU - Liu, Xin

AU - He, Xia

AU - Zhang, Li Ling

AU - Wu, Gang

AU - Qu, Bao Lin

AU - Qian, Li Ting

AU - Hou, Xiao Rong

AU - Zhang, Fu Quan

AU - Qiao, Xue Ying

AU - Wang, Hua

AU - Li, Gao Feng

AU - Zhu, Yuan

AU - Cao, Jian Zhong

AU - Wu, Jun Xin

AU - Wu, Tao

AU - Zhu, Su Yu

AU - Shi, Mei

AU - Xu, Li Ming

AU - Su, Hang

AU - Song, Yu Qin

AU - Zhu, Jun

AU - Zhang, Yu Jing

AU - Huang, Hui Qiang

AU - Hu, Chen

AU - Qi, Shu Nan

AU - Li, Ye Xiong

PY - 2021/9

Y1 - 2021/9

N2 - Table 3 of the original article was not correct. The corrected version can be found below.

AB - Table 3 of the original article was not correct. The corrected version can be found below.

UR - http://www.scopus.com/inward/record.url?scp=85111896575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85111896575&partnerID=8YFLogxK

U2 - 10.1038/s41375-021-01371-6

DO - 10.1038/s41375-021-01371-6

M3 - Comment/debate

C2 - 34341480

AN - SCOPUS:85111896575

SN - 0887-6924

VL - 35

SP - 2736

EP - 2737

JO - Leukemia

JF - Leukemia

IS - 9

ER -

Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study (Leukemia, (2021), 35, 6, (1671-1682), 10.1038/s41375-020-01042-y)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this